The strategy captures companies developing and producing peptide-based products while manufacturing demand outpaces supply.
Rex Shares has further expanded its exchange-traded fund (ETF) portfolio lineup with the launch of the Rex Peptide ETF (PEPT), a thematic strategy aimed at capturing the full peptide economy value chain. The ETF holds companies involved in developing, manufacturing, delivering and commercialising peptide-based products, broadening exposure beyond the two drugmakers that dominate today’s glucagon-like peptide-1 (GLP-1) market. Peptides are signalling molecules re-engineered